FdaApplication
ANDA 219985
Identifiers
- fda_app_no: ANDA219985
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2026-03-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE | EQ 30MG BASE | CAPSULE;ORAL |
1 product